The Philippines pharmaceuticals and healthcare sectorﷺ is entering a phase of accelerated growth. T♐he Philippines economy has grown considerably over the recent years, creating a growing middle-class population with the means to access ...

The SEA region has had an admir🐻able record in improving its record against infectious diseases over the nearly three decades from 1990 to 2019. The region’s rapid economic growth relative to the rest of the world has contributed to ...

Indonesia’s pha✨rmaceuticals and healthcare sector is one of the fastest-growing in the ASEAN region. The Indon♌esian government has prioritised widening healthcare access and increasing the healthcare system’s capacity since 2014. However, ...

Malaysia has one of the ASEAN region’s most developed pharmaceutꦛicals and healthcare sectors. Malaysia has a two-tiered system in which the government, under the Ministry of Health, operates healthcare facilities and regulates medical practice ...

Latin America was among the hardest-hit regions by the COVID-19 pandemic. The novel coronavirus entered the region at ⛄a bad time. The commodities boom at end of the 2000s combined with several local crises afterwards have hurt badly the public ...

Although Thailand’s pharmaceuticals and healthcare sec𒈔tor has developed considerably over the past few decades, there is still considerable runway for further growth. Thailand stands out amongst emerging market countries for offering universal ...

Colombia was the fourth-largest pharmaಞceutical market in Latin America in terms of sales volume in 2019, with a large and growing population, a universal but underfunded social security health insurance system, and a small but rapidly ...

Brazil was one of the hardest-hit nations by the COVID-19 pandemic on a global scale, ranking among the top thജree countries with the highest number of cases and deaths from the novel coronavirus. Brazil’s pharmaceutical industry, ...

Mexico is the second-largest pharmaceutical market in Latin America, after Brazil, with re꧅tail drug sales of USD 7.3bn in 2019. The country has a growing and ageing population, multiple but underfunded state-run health insurance systems, ...

Argentina is the third-largest pharmaceuti☂cal market in Latin America, with retail drug sales of USD 4.7bn in 2019. The country has a large and ageing population, a relatively developed public health system, and a small but consolidated ...